MKS Instruments shares jumped 7.9% in the most recent trading session, with daily volume swelling to approximately 130,000 shares, well above the three-month average of 85,000. The sharp move reflects renewed investor interest following a string of positive analyst notes and comes as the stock reclaimed its 50-day moving average, signaling potential for further technical strength.

Wells Fargo & Company upgraded the stock’s outlook from equal weight to an adjusted price target of 175, marking a 17% lift from its prior 150 objective. Cantor Fitzgerald affirmed its overweight stance with a 200 target, while Mizuho increased its goal to 215. Citigroup, Morgan Stanley and Goldman Sachs also refreshed their models, contributing to a consensus ‘Moderate Buy’ rating and an average target near 183.

In the latest quarter, MKS reported revenue of $988 million, up 10.3% year-over-year, and delivered non-GAAP EPS of $1.93, beating the consensus estimate by $0.13. Return on equity exceeded 20%, and net margin topped 7%. Management set Q4 guidance for EPS between 1.93 and 2.61, while full-year consensus forecasts stand at roughly 6.94 per share, underscoring continued top-line momentum in semiconductor and life-science end markets.

Director Elizabeth Mora sold 300 shares in early December, reducing her holdings by 1.56% and realizing proceeds of about 47,600. Institutional ownership remains elevated at nearly 100%, led by UBS Asset Management’s 267,400-share stake and new positions from Wedmont Private Capital and Assenagon Asset Management. These shifts highlight growing confidence among large investors in MKS’s growth trajectory.